Last reviewed · How we verify
A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)
The purpose of this study is to investigate the safety, pharmacokinetics, and pharmacodynamics of repeated dosing of TS-142 when administered once daily to healthy Japanese non-elderly participants.
Details
| Lead sponsor | Taisho Pharmaceutical Co., Ltd. |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 24 |
| Start date | Wed Jul 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Oct 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Healthy Volunteer
Interventions
- Placebo
- TS-142, 10 mg
- TS-142, 20 mg
- TS-142, 30 mg
Countries
Japan